Get all your news in one place.
100's of premium titles.
One app.
Start reading
International Business Times UK
International Business Times UK
Shyna Mae Deang

Eli Lilly CEO David Ricks Unveils $6B Alabama Plant to Produce New Obesity Pill

Eli Lilly CEO David Ricks has announced a new $6 billion manufacturing plant in Alabama dedicated to producing the company’s next-generation obesity pill. The move signals Lilly’s aggressive expansion as global demand for weight-loss drugs soars. (Credit: Wikimedia Commons)

Eli Lilly CEO David A. Ricks has unveiled one of the most ambitious expansions in the pharmaceutical titan's history: a $6 billion manufacturing facility in Greenbrier South, Huntsville, Alabama, dedicated to producing the next generation of obesity medicines.

The plant will focus primarily on orforglipron, Lilly's highly anticipated once-daily oral obesity treatment, which analysts say could reshape a pharmaceutical market currently dominated by injectables.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.